Relay Therapeutics (RLAY) Interest Expenses (2019 - 2023)
Relay Therapeutics (RLAY) reported Interest Expenses of $3000.0 for Q1 2023, down 85.71% year-over-year from $21000.0 in Q1 2022, and down 85.71% quarter-over-quarter from $21000.0 in Q1 2022.
Relay Therapeutics (RLAY) Interest Expenses (2019 - 2023) Analysis & Trends
Relay Therapeutics (RLAY) has 5 years of Interest Expenses data on file, last reported at $3000.0 in Q1 2023.
- Interest Expenses for Q1 2023 came in at $3000.0, down 85.71% year-over-year; the trailing twelve-month figure through Dec 2023 was $3000.0 (down 85.71% YoY), and the FY2021 annual result was $4000.0, down 75.0% from the prior year.
- Interest Expenses fell to $3000.0 in Q1 2023 per RLAY's latest filing, from $21000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $21000.0 in Q1 2022 and troughed at $1000.0 in Q3 2019.
- A 5-year average of $6571.4 and a median of $5000.0 in 2020 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2020 and 2023: Interest Expenses surged 400.0% in 2020, then plunged 85.71% in 2023.
- A 5-year view of Interest Expenses shows it stood at $1000.0 in 2019, then soared by 700.0% to $8000.0 in 2020, then tumbled by 37.5% to $5000.0 in 2021, then surged by 320.0% to $21000.0 in 2022, then plunged by 85.71% to $3000.0 in 2023.
- Business Quant data shows RLAY's Interest Expenses at $3000.0 in Q1 2023, $21000.0 in Q1 2022, and $5000.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Sep 30, 2019 | 1,000.00 |